Stay updated with breaking news from Ww Smith Charitable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the often male-dominated landscape of STEM, Temple University proudly boasts a talented and diverse roster of women who have carved out their niches and made lasting impacts on their respective fields. As we celebrate Women’s History Month, we applaud our women faculty who are not only pushing the boundaries of what is known, but also inspiring the next generation of women
PHILADELPHIA, PA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the...
Zachary Schug, Ph.D., assistant professor at The Wistar Institute, has published a new paper in the journal Nature Cancer demonstrates a double-acting mechanism for fighting a particularly aggressive, difficult-to-treat form of breast cancer. Schug’s research shows how silencing a certain gene, ACSS2, may improve existing treatments for patients.
Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn't worked as well for solid tumors.
A new vaccine boosts the response of engineered CAR-T cells and helps the immune system generate T cells that target other tumor antigens. The researchers found this approach made it more likely that a tumor can be eradicated in mice.